|
Volumn 10, Issue 1, 2007, Pages 8-10
|
EORTC-NCI-AACR - 18th symposium - Molecular targets and cancer therapeutics. New approaches in treating cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
7 ETHYL 10 HYDROXYCAMPTOTHECIN;
ABT 888;
AMINOPEPTIDASE;
AURORA KINASE INHIBITOR;
BMS 690514;
BN 2629;
BORTEZOMIB;
CANCER VACCINE;
CISPLATIN;
ENZYME INHIBITOR;
HBX 90397;
HBX 90659;
HISTONE DEACETYLASE INHIBITOR;
INTERLEUKIN 2;
IRINOTECAN;
JNJ 46483327;
LOBAPLATIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY L 19;
MP 235;
MP 529;
NVP TAE 226;
PEG SN 38;
PHA 739358;
PPI 2458;
PROTEIN MDM2;
PROTEIN P53;
RHPS 4;
SB 939;
SG 2057;
SGI 1097;
SGI 1215;
SGI 498;
SGI 503;
TAE 226;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
CYCLOBUTANE DERIVATIVE;
MDM2 PROTEIN, HUMAN;
METALLOPROTEINASE;
METHIONINE AMINOPEPTIDASE 2;
PLATINUM COMPLEX;
PROTEIN KINASE INHIBITOR;
PROTEINASE;
UBIQUITIN ISOPEPTIDASE;
ANGIOGENESIS;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
BREAST CANCER;
CANCER IMMUNIZATION;
CANCER RISK;
CANCER THERAPY;
CELL CYCLE ARREST;
CLINICAL TRIAL;
COLON CARCINOMA;
COLORECTAL CANCER;
CONFERENCE PAPER;
DRUG SOLUBILITY;
DRUG STABILITY;
EMBRYONIC STRUCTURES;
HUMAN;
LEWIS CARCINOMA;
LIVER CELL CARCINOMA;
MELANOMA;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
NONHUMAN;
PANCREAS CANCER;
PLASMACYTOMA;
RECOMMENDED DRUG DOSE;
SINGLE DRUG DOSE;
SINGLE NUCLEOTIDE POLYMORPHISM;
SOLID TUMOR;
TUMOR GROWTH;
TUMOR REGRESSION;
TUMOR VASCULARIZATION;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
EMBRYONIC STEM CELL;
GENETICS;
NEOPLASM;
TELOMERE;
TRANSPLANTATION;
AMINOPEPTIDASES;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
CYCLOBUTANES;
EMBRYONIC STEM CELLS;
ENDOPEPTIDASES;
HUMANS;
METALLOENDOPEPTIDASES;
NEOPLASMS;
ORGANOPLATINUM COMPOUNDS;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-MDM2;
TELOMERE;
|
EID: 33947309700
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|